BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang JJ, Tao H, Li J. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives. Expert Opin Ther Targets. 2014;18:1011-1021. [PMID: 24935558 DOI: 10.1517/14728222.2014.927443] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Jung YK, Yim HJ. Reversal of liver cirrhosis: current evidence and expectations. Korean J Intern Med. 2017;32:213-228. [PMID: 28171717 DOI: 10.3904/kjim.2016.268] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 9.8] [Reference Citation Analysis]
2 Ni MM, Wang YR, Wu WW, Xia CC, Zhang YH, Xu J, Xu T, Li J. Novel Insights on Notch signaling pathways in liver fibrosis. Eur J Pharmacol 2018;826:66-74. [PMID: 29501868 DOI: 10.1016/j.ejphar.2018.02.051] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
3 Yang JJ, Tao H, Deng ZY, Lu C, Li J. Non-coding RNA-mediated epigenetic regulation of liver fibrosis. Metabolism 2015;64:1386-94. [PMID: 26362725 DOI: 10.1016/j.metabol.2015.08.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
4 Tang V, Cofer ZC, Cui S, Sapp V, Loomes KM, Matthews RP. Loss of a Candidate Biliary Atresia Susceptibility Gene, add3a, Causes Biliary Developmental Defects in Zebrafish. J Pediatr Gastroenterol Nutr 2016;63:524-30. [PMID: 27526058 DOI: 10.1097/MPG.0000000000001375] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
5 Karsdal MA, Manon-Jensen T, Genovese F, Kristensen JH, Nielsen MJ, Sand JM, Hansen NU, Bay-Jensen AC, Bager CL, Krag A, Blanchard A, Krarup H, Leeming DJ, Schuppan D. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2015;308:G807-30. [PMID: 25767261 DOI: 10.1152/ajpgi.00447.2014] [Cited by in Crossref: 138] [Cited by in F6Publishing: 132] [Article Influence: 19.7] [Reference Citation Analysis]
6 He Z, Yang D, Fan X, Zhang M, Li Y, Gu X, Yang M. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Int J Mol Sci 2020;21:E1482. [PMID: 32098245 DOI: 10.3390/ijms21041482] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
7 Rzeszotarska E, Sowinska A, Stypinska B, Walczuk E, Wajda A, Lutkowska A, Felis-Giemza A, Olesinska M, Puszczewicz M, Majewski D, Jagodzinski PP, Czerewaty M, Malinowski D, Pawlik A, Jaronczyk M, Paradowska-Gorycka A. The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus. Biomolecules 2020;10:E494. [PMID: 32214033 DOI: 10.3390/biom10030494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lin JW, Wang H. Progress in research of cancer stem cells. Shijie Huaren Xiaohua Zazhi 2017; 25(31): 2776-2781 [DOI: 10.11569/wcjd.v25.i31.2776] [Reference Citation Analysis]
9 Wang F, Zhao LJ. Cell lineage tracing in study of epithelial-to-mesenchymal transition during hepatic fibrosis. Shijie Huaren Xiaohua Zazhi 2015; 23(20): 3235-3240 [DOI: 10.11569/wcjd.v23.i20.3235] [Reference Citation Analysis]
10 Bernstein A, Reichert SNA, Südkamp NP, Hernandez SL, Nerlich AG, Kühle J, Mayr HO. Expression of xylosyltransferases I and II and their role in the pathogenesis of arthrofibrosis. J Orthop Surg Res 2020;15:27. [PMID: 31973761 DOI: 10.1186/s13018-020-1544-8] [Reference Citation Analysis]
11 Niewiadomski P, Niedziółka SM, Markiewicz Ł, Uśpieński T, Baran B, Chojnowska K. Gli Proteins: Regulation in Development and Cancer. Cells 2019;8:E147. [PMID: 30754706 DOI: 10.3390/cells8020147] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 14.3] [Reference Citation Analysis]
12 Wei A, Zhao F, Hao A, Liu B, Liu Z. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway. Gene 2021;813:146125. [PMID: 34921949 DOI: 10.1016/j.gene.2021.146125] [Reference Citation Analysis]
13 Wang L, Yan W, Wang J. Silencing MEKK3 attenuates cardiomyocyte injury caused by hypoxia/reoxygenation via the sonic hedgehog pathway. J Cell Physiol 2019. [PMID: 30712259 DOI: 10.1002/jcp.28162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Li L, Zhang L, Zhao X, Cao J, Li J, Chu G. Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro. Exp Ther Med 2019;18:425-34. [PMID: 31258681 DOI: 10.3892/etm.2019.7595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Hu J, Cao G, Wu X, Cai H, Cai B. Tetramethylpyrazine Inhibits Activation of Hepatic Stellate Cells through Hedgehog Signaling Pathways In Vitro. Biomed Res Int. 2015;2015:603067. [PMID: 26380286 DOI: 10.1155/2015/603067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
16 Lin X, Li J, Xing Y. Geniposide, a sonic hedgehog signaling inhibitor, inhibits the activation of hepatic stellate cell. International Immunopharmacology 2019;72:330-8. [DOI: 10.1016/j.intimp.2019.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
17 Wang Z, Yang X, Gui S, Yang F, Cao Z, Cheng R, Xia X, Li C. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Front Pharmacol 2021;12:779606. [PMID: 34899344 DOI: 10.3389/fphar.2021.779606] [Reference Citation Analysis]
18 Dutta R, Kumar V, Peng Y, Evande RE, Grem JL, Mahato RI. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice. Pharm Res 2017;34:564-78. [DOI: 10.1007/s11095-016-2081-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
19 Li H, Hua J, Guo CX, Wang WX, Wang BJ, Yang DL, Wei P, Lu YP. Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway. J Huazhong Univ Sci Technolog Med Sci 2016;36:372-6. [PMID: 27376806 DOI: 10.1007/s11596-016-1594-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Valizadeh A, Majidinia M, Samadi-Kafil H, Yousefi M, Yousefi B. The roles of signaling pathways in liver repair and regeneration. J Cell Physiol. 2019;. [PMID: 30770551 DOI: 10.1002/jcp.28336] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
21 Sundaram SS, Swiderska-Syn M, Sokol RJ, Halbower AC, Capocelli KE, Pan Z, Robbins K, Graham B, Diehl AM. Nocturnal Hypoxia Activation of the Hedgehog Signaling Pathway Affects Pediatric Nonalcoholic Fatty Liver Disease Severity. Hepatol Commun 2019;3:883-93. [PMID: 31334441 DOI: 10.1002/hep4.1354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Dattaroy D, Seth RK, Sarkar S, Kimono D, Albadrani M, Chandrashekaran V, Hasson FA, Singh UP, Fan D, Nagarkatti M, Nagarkatti P, Diehl AM, Chatterjee S. Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent. Eur J Pharmacol 2018;841:33-48. [PMID: 30194936 DOI: 10.1016/j.ejphar.2018.08.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
23 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Alipoor B, Nikouei S, Rezaeinejad F, Malakooti-Dehkordi SN, Sabati Z, Ghasemi H. Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets. J Endocrinol Invest 2021;44:2015-41. [PMID: 33792864 DOI: 10.1007/s40618-021-01559-8] [Reference Citation Analysis]
25 Weiskirchen R. Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. Front Pharmacol. 2015;6:303. [PMID: 26779021 DOI: 10.3389/fphar.2015.00303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
26 El Agha E, Kramann R, Schneider RK, Li X, Seeger W, Humphreys BD, Bellusci S. Mesenchymal Stem Cells in Fibrotic Disease. Cell Stem Cell. 2017;21:166-177. [PMID: 28777943 DOI: 10.1016/j.stem.2017.07.011] [Cited by in Crossref: 155] [Cited by in F6Publishing: 149] [Article Influence: 38.8] [Reference Citation Analysis]
27 Guo X, Zhang H, Zhang Q, Li X, Liu L. Screening for and validation of a hepatic fibrosis-related pathway induced by insulin-like growth factor-binding protein-related protein 1: . European Journal of Gastroenterology & Hepatology 2016;28:762-72. [DOI: 10.1097/meg.0000000000000631] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Zhi S, Chen S, Li Y, Li J, Zheng Y, Yu F. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis. Dig Dis Sci 2019;64:1560-70. [DOI: 10.1007/s10620-019-5462-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
29 El-Agroudy NN, El-Naga RN, El-Razeq RA, El-Demerdash E. Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride-induced liver fibrosis in rats. Br J Pharmacol. 2016;173:3248-3260. [PMID: 27590029 DOI: 10.1111/bph.13611] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
30 Ortiz-Perez A, Donnelly B, Temple H, Tiao G, Bansal R, Mohanty SK. Innate Immunity and Pathogenesis of Biliary Atresia. Front Immunol 2020;11:329. [PMID: 32161597 DOI: 10.3389/fimmu.2020.00329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
31 Gao W, Sun J, Wang F, Lu Y, Wen C, Bian Q, Wu H. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway. Biochem Biophys Res Commun 2019;516:1222-8. [PMID: 31296386 DOI: 10.1016/j.bbrc.2019.07.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
32 Yang JJ, Tao H, Liu LP, Hu W, Deng ZY, Li J. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway. Inflamm Res 2017;66:341-52. [PMID: 28025657 DOI: 10.1007/s00011-016-1020-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
33 Ma L, Li C, Lian S, Xu B, Lv H, Liu Y, Lu J, Ji H, Li S, Guo J, Yang H. Procyanidin B2 alleviates liver injury caused by cold stimulation through Sonic hedgehog signalling and autophagy. J Cell Mol Med 2021;25:8015-27. [PMID: 34155807 DOI: 10.1111/jcmm.16733] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Gan GN, Jimeno A. Emerging from their burrow: Hedgehog pathway inhibitors for cancer. Expert Opinion on Investigational Drugs 2016;25:1153-66. [DOI: 10.1080/13543784.2016.1216973] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
35 Zeng ZP, Guo JS. Mechanisms and treatment of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2017; 25(7): 569-575 [DOI: 10.11569/wcjd.v25.i7.569] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Feng J, Wang C, Liu T, Li J, Wu L, Yu Q, Li S, Zhou Y, Zhang J, Chen J, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis. J Cell Mol Med 2019;23:6479-93. [PMID: 31328391 DOI: 10.1111/jcmm.14543] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
37 He S, Barron E, Ishikawa K, Nazari Khanamiri H, Spee C, Zhou P, Kase S, Wang Z, Dustin LD, Hinton DR. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci 2015;56:5579-89. [PMID: 26305530 DOI: 10.1167/iovs.14-16258] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
38 Chen X, Li XF, Chen Y, Zhu S, Li HD, Chen SY, Wang JN, Pan XY, Bu FT, Huang C, Li J. Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms. Int Immunopharmacol 2019;76:105838. [PMID: 31473406 DOI: 10.1016/j.intimp.2019.105838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]